News releases

Advancing new and underused innovations to end preventable death in childbirth

Game-changing innovations that make the difference
Unitaid has invested more than US$77 million in innovative tools and treatments that diagnose, monitor, and manage life-threatening bleeding in childbirth. Our work helps address barriers that stop critical products from reaching women when and where they need them – whether they give birth in a hospital, clinic, or at home.

Watch the videos to see how these four products are transforming maternal and newborn health.

Calibrated drape – early detection of hemorrhage

This simple yet effective tool helps healthcare workers quickly measure blood loss after childbirth, enabling faster diagnosis and treatment of postpartum hemorrhage.

Heat-stable carbetocin – preventing excessive bleeding

Heat-stable carbetocin prevents dangerous bleeding after birth and requires no refrigeration, making it a reliable option in low-resource settings where cold storage is unreliable.

Tranexamic acid – emergency bleeding control

This fast-acting medicine promotes blood clotting. Administered quickly after delivery, it can significantly reduce the risk of death from postpartum hemorrhage. It is especially valuable in emergency situations where time is critical.

Misoprostol – accessible and effective

Affordable, heat-stable, and easy to use – even outside of clinical settings, Misoprostol is a practical and scalable option for remote or underserved communities.